Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Unicycive Therapeutics, Inc. - Common Stock (NQ:UNCY)

4.645 -0.055 (-1.17%)
Delayed Quote Updated: 3:01 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 765,685
Open 4.710
Bid (Size) 4.640 (200)
Ask (Size) 4.650 (900)
Prev. Close 4.700
Today's Range 4.560 - 4.760
52wk Range 3.930 - 8.740
Shares Outstanding 14,508,063
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is November 2, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate
Unicycive Therapeutics, Inc. (Nasdaq: UNCY) today announced the resubmission of its New Drug Application (NDA) for oxylanthanum carbonate (OLC), the Company’s investigational oral phosphate binder for... 
Via B2i Digital

Performance

YTD
-19.9%
-19.9%
1 Month
-10.7%
-10.7%
3 Month
-12.0%
-12.0%
6 Month
-34.8%
-34.8%
1 Year
+6.5%
+6.5%

More News

Read More
News headline image
Kaplan Fox Deadline Alert: Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors Have Until November 2, 2026 to Seek a Lead Plaintiff Role
Via NewMediaWire
Topics Lawsuit
News headline image
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Contact the Firm Before the Deadline on November 2, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 2, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Robbins LLP Urges UNCY Stockholders Who Lost Money Investing in Unicycive Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action
From Robbins LLP
Via Business Wire
News headline image
Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to Contact the Firm Before Lead Plaintiff Deadline on November 2, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Reminds Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to a Securities Class Action Deadline - Contact the Firm Before November 2, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Robbins LLP is Investigating Allegations that Unicycive Therapeutics, Inc. Failed to Properly Inspect its Third-Party Vendor's Manufacturing Facility to Ensure it Resolved the FDA's Previously Noted Deficiencies
Via Newsfile
Topics Lawsuit
News headline image
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
UNICYCIVE INVESTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Unicycive Therapeutics, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Levi & Korsinsky Reminds Unicycive Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 2, 2026 - UNCY
From Levi & Korsinsky, LLP
Via Business Wire
News headline image
UNCY INVESTOR REMINDER: Unicycive Therapeutics, Inc. Investors Have Until November 2, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role
From Kirby McInerney LLP
Via Business Wire
News headline image
Kaplan Fox Encourages Investors of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) to Contact the Firm to Learn About Their Legal Rights
Via NewMediaWire
Topics Lawsuit
News headline image
Deadline Alert: Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Law Offices of Frank R. Cruz Encourages Unicycive Therapeutics, Inc. (UNCY) Shareholders To Inquire About Securities Fraud Class Action
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
UNCY DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (NASDAQ: UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Deadline Approaching: Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Deadline Soon: Unicycive Therapeutics, Inc. (UNCY) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – UNCY
From DJS Law Group
Via Business Wire
News headline image
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire

Frequently Asked Questions

Is Unicycive Therapeutics, Inc. - Common Stock publicly traded?
Yes, Unicycive Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Unicycive Therapeutics, Inc. - Common Stock trade on?
Unicycive Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Unicycive Therapeutics, Inc. - Common Stock?
The ticker symbol for Unicycive Therapeutics, Inc. - Common Stock is UNCY on the Nasdaq Stock Market
What is the current price of Unicycive Therapeutics, Inc. - Common Stock?
The current price of Unicycive Therapeutics, Inc. - Common Stock is 4.645
When was Unicycive Therapeutics, Inc. - Common Stock last traded?
The last trade of Unicycive Therapeutics, Inc. - Common Stock was at 10/01/26 03:01 PM ET
What is the market capitalization of Unicycive Therapeutics, Inc. - Common Stock?
The market capitalization of Unicycive Therapeutics, Inc. - Common Stock is 67.39M
How many shares of Unicycive Therapeutics, Inc. - Common Stock are outstanding?
Unicycive Therapeutics, Inc. - Common Stock has 67M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.